Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Mapi Pharma announced an additional investment from Mylan in support of continued study progress to bring to market in the U.S. Glatiramer Acetate Depot.
read more
Tuesday, January 21, 2020
Cipher announced the Company received a Notice of Termination from Bausch Health in connection with the License, Development and Commercialization Agreement of Trulance.
read more
Wednesday, September 19, 2018
Legacy Health has selected Trellis Rx, a leading technology-enabled specialty pharmacy service provider, to help Legacy launch a patient-centered specialty pharmacy program.
read more
Friday, September 21, 2018
The FDA is finalizing two guidance documents and making available one draft guidance to help ensure that prescription drug products are identified and traced properly as they move through the supply chain in compliance with federal law.
read more
Ampersand Capital Partners has appointed Patrick D. Walsh as Chief Executive Officer of Avista Pharma Solutions and Accuratus Labs.
read more
Logistics4Pharma GmbH announced an expansion to it capabilities with a recent investment in ultra-deep-freeze (UDF) warehousing for temperatures as low as -80 Deg C that enables the storage of highly sensitive medicines such as proteins and COVID-19 ...
read more
Andelyn Biosciences has manufactured a viral vector with its AAV Curator® Platform for the Nationwide Children’s Hospital’s Cellular Therapy and Cancer Immunology Program. The Adeno-Associated Virus (AAV) will be utilized in a novel cell therapy for ...
read more
Tuesday, October 10, 2017
Protea Biosciences announced it plans to develop clinical screening assays in various areas of oncology.
read more
Thursday, February 18, 2021
ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
read more
Wednesday, September 30, 2015
Merck expects the Latin America region to keep driving growth at its Consumer Health business, as demand for consumer goods in the region is constantly rising.
read more
Lonza and Integral Molecular announced a strategy to offer complementary expertise to their respective customers to better assess the risks of off-target binding of biologic drug candidates.
read more
Novartis announced Shannon Thyme Klinger, Chief Legal Officer, has decided to resign from Novartis and return to the US to take an executive role at a biotechnology company.
read more
Imprimis Pharmaceuticals, a pharmaceutical company focused on the development and commercialization of proprietary and customizable drug formulations, announced that it has filed for registration of its ImprimisRx TX pharmacy, located in Allen, Texas...
read more
Wednesday, December 14, 2016
The Wisconsin Technology Innovation Initiative (Wi2), a non-profit organization formed to support the School of Medicine and Public Health at the University of Wisconsin-Madison, and Orion Corporation, a Finnish pharmaceutical and diagnostics ...
read more
Made Scientific and Pluristyx announced a strategic partnership to integrate Pluristyx Technology including GMP iPSC lines and derivative cell types, including induced natural killer (iNK) cells and induced mesenchymal stem cells (iMSCs), into Made ...
read more